# Labcorp Drug Development, Princeton, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/labcorp-drug-development/590644d8-047e-4701-b6f2-fcb4b881a7a1

> Inspection records and compliance data for Labcorp Drug Development in Princeton, New Jersey. 7 FDA inspections on record, last inspected April 25, 2022.

---

## Details

- Name: Labcorp Drug Development
- FEI Number: 2242945
- Address Line 1: 206 Carnegie Ctr
- City: Princeton
- State: New Jersey
- Zip Code: 08540
- Country Name: United States
- Address: 206 Carnegie Ctr, Princeton, New Jersey 08540, United States
- Country: United States

## Related Documents

- [FDA Inspection 1168630 - Labcorp Drug Development - 2022-04-25](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/a50d857a-14b9-4f79-ab98-34070136da78) — classification: No Action Indicated (NAI), source: FDA, date: April 25, 2022
- [FDA Inspection 1147393 - Labcorp Drug Development - 2021-06-17](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/0660c639-f996-40ed-a7c4-41507f3a7f5f) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2021
- FDA Inspection 1123056 - Labcorp Drug Development - 2020-03-05 — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2020
- [FDA Inspection 1064469 - Labcorp Drug Development - 2018-07-19](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/c78bb744-2d8a-40c2-8327-03479ad282f0) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2018
- FDA Inspection 1022660 - Labcorp Drug Development - 2017-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2017
- FDA Inspection 790402 - Labcorp Drug Development - 2012-07-13 — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2012
- [FDA Inspection 597131 - Labcorp Drug Development - 2009-07-15](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/5806956b-537e-4c1d-a36f-7499bc795eb3) — classification: No Action Indicated (NAI), source: FDA, date: July 15, 2009

## Related Companies

- [Encore Pharmaceutical Inc.](https://www.keypedia.com/companies/encore-pharmaceutical-inc/5f33a86a-f59d-4378-b150-1cfe9171bde0)
- [Amarin Pharma Inc.](https://www.keypedia.com/companies/amarin-pharma-inc/dd301a42-2e08-4db9-929f-eaf4891ffad7)
- [Thomas Birch, M.D.](https://www.keypedia.com/companies/thomas-birch-md/9409f269-c3c2-4cd4-bade-7e5738379418)
- [P F Laboratories, Inc.](https://www.keypedia.com/companies/p-f-laboratories-inc/72ae47b1-b097-41af-b169-eadb718559e0)
- [Jane M. Lee, M.D.](https://www.keypedia.com/companies/jane-m-lee-md/097e9bad-e127-4b6b-817b-b46976a126a0)
- [Edenbridge Pharmaceuticals, LLC](https://www.keypedia.com/companies/edenbridge-pharmaceuticals-llc/7b2e8a53-1d26-4288-bb3b-8f99ccbf3053)
- [Akorn Operating Company LLC](https://www.keypedia.com/companies/akorn-operating-company-llc/253ec8c7-03e0-488d-833d-e86734d0e15b)
- [Biovail Technologies, Ltd](https://www.keypedia.com/companies/biovail-technologies-ltd/336d706b-5af4-4730-8447-3cddb3411f84)
- [GlaxoSmithKline Consumer Healthcare, LP](https://www.keypedia.com/companies/glaxosmithkline-consumer-healthcare-lp/0e686548-cf93-4039-837a-fe214d86b6e9)
- [Univar Solutions USA LLC](https://www.keypedia.com/companies/univar-solutions-usa-llc/07ff4d14-2588-47ce-9b80-888e49e56e92)